Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

BOPA 2017 | Pancreatic cancer: The next 10 years

Derek Grose • 6 Oct 2017
BOPA 2017
Pancreatic Cancer

This is an exciting time for pancreatic cancer research, with advances in immunotherapy, genomic sequencing and druggable targets. What the next 10 years may look like for pancreatic cancer research is discussed by Derek Grose, MBChB, MRCP, FRCR, MD of the Beatson West of Scotland Cancer Centre, Glasgow at the British Oncology Pharmacy Association (BOPA) 20th Annual Symposium 2017 in Glasgow, UK. In particular, he discusses the need for improving and speeding up clinical trials for this patient group moving forwards.

More from Derek Grose

3:01
The PRECISION-Panc project: Speeding up scientific discovery to improve pancreatic cancer survival
Derek Grose • 6 Oct 2017
1:35
Upcoming pancreatic cancer study: PRIMUS001
Derek Grose • 6 Oct 2017
2:03
The current treatment landscape for pancreatic cancer
Derek Grose • 6 Oct 2017
1:04
The current outlook for pancreatic cancer patients and importance of further research
Derek Grose • 6 Oct 2017

Related Videos

4:12
PETRA: saruparib in solid tumors with BRCA1/2, PALB2 or RAD51C/D mutations
Timothy Yap • 7 Apr 2024
1:16
Entinostat with nivolumab in pancreatic ductal adenocarcinoma
Marina Baretti • 9 Apr 2024
0:40
The limited therapeutic efficacy of checkpoint inhibitors for pancreatic cancer
Olatunji Alese • 8 Apr 2024
0:48
Siltuximab and spartalizumab in advanced pancreatic adenocarcinoma
Olatunji Alese • 8 Apr 2024
The content of VJOncology is intended for healthcare professionals